Literature DB >> 8845761

Structural similarity between ornithine and aspartate transcarbamoylases of Escherichia coli: characterization of the active site and evidence for an interdomain carboxy-terminal helix in ornithine transcarbamoylase.

L B Murata1, H K Schachman.   

Abstract

Predictions of tertiary structures of proteins from their amino acid sequences are facilitated greatly when the structures of homologous proteins are known. On this basis, structural features of Escherichia coli ornithine transcarbamoylase (OTCase) were investigated by site-directed mutagenesis experiments based on the known tertiary structure of the catalytic (c) chain of E. coli aspartate transcarbamoylase (ATCase). In ATCase, each c chain is composed of two globular domains connected by two interdomain helices, one of which is near the C-terminus and is critical for the in vivo folding of the chains and their assembly into trimers. Each active site is located at the interface between two chains and requires the participation of residues from each of the adjacent chains. OTCase, a trimeric enzyme, has been proposed to be similar in structure to the ATCase trimer on the basis of sequence identity (32%), the nature of the reaction catalyzed by the enzyme, and secondary structure predictions. As shown here, analysis of OTCase and ATCase sequences revealed extensive evolutionary conservation in portions corresponding to the ATCase active site and the C-terminal helix. Truncations and substitutions within the predicted C-terminal helix of OTCase had effects on activity and thermal stability strikingly similar to those caused by analogous alterations in ATCase. Similarly, substitutions at either of two conserved residues, Ser 55 and Lys 86, in the proposed active site of OTCase had deleterious effects parallel to those caused by the analogous ATCase substitutions. Hybrid trimers comprised of chains from both these relatively inactive OTCase mutants exhibited dramatically increased activity, as predicted for shared active sites located at the chain interfaces. These results strongly support the hypothesis that the tertiary and quaternary structures of the two enzymes are similar.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8845761      PMCID: PMC2143393          DOI: 10.1002/pro.5560050416

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  51 in total

1.  Differential scanning calorimetry of asparate transcarbamoylase and its isolate subunits.

Authors:  L P Vickers; J W Donovan; H K Schachman
Journal:  J Biol Chem       Date:  1978-12-10       Impact factor: 5.157

Review 2.  Empirical predictions of protein conformation.

Authors:  P Y Chou; G D Fasman
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

3.  Aspartate transcarbamoylase (Escherichia coli): preparation of subunits.

Authors:  Y R Yang; M W Kirschner; H K Schachman
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

4.  Location of amino acid alterations in mutants of aspartate transcarbamoylase: Structural aspects of interallelic complementation.

Authors:  H K Schachman; C D Pauza; M Navre; M J Karels; L Wu; Y R Yang
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

5.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

6.  Nucleotide sequence of the structural gene (pyrB) that encodes the catalytic polypeptide of aspartate transcarbamoylase of Escherichia coli.

Authors:  T A Hoover; W D Roof; K F Foltermann; G A O'Donovan; D A Bencini; J R Wild
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

7.  Crystal and molecular structures of native and CTP-liganded aspartate carbamoyltransferase from Escherichia coli.

Authors:  R B Honzatko; J L Crawford; H L Monaco; J E Ladner; B F Ewards; D R Evans; S G Warren; D C Wiley; R C Ladner; W N Lipscomb
Journal:  J Mol Biol       Date:  1982-09-15       Impact factor: 5.469

8.  Synthesis and properties of delta-N-(phosphonacetyl)-L-ornithine. A transition-state analog inhibitor of ornithine transcarbamylase.

Authors:  N J Hoogenraad
Journal:  Arch Biochem Biophys       Date:  1978-05       Impact factor: 4.013

9.  The organization and regulation of the pyrBI operon in E. coli includes a rho-independent attenuator sequence.

Authors:  W D Roof; K F Foltermann; J R Wild
Journal:  Mol Gen Genet       Date:  1982

10.  The DNA sequence of argI from Escherichia coli K12.

Authors:  D A Bencini; J E Houghton; T A Hoover; K F Foltermann; J R Wild; G A O'Donovan
Journal:  Nucleic Acids Res       Date:  1983-12-10       Impact factor: 16.971

View more
  5 in total

1.  Substrate-induced conformational change in a trimeric ornithine transcarbamoylase.

Authors:  Y Ha; M T McCann; M Tuchman; N M Allewell
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Expression, purification and kinetic characterization of wild-type human ornithine transcarbamylase and a recurrent mutant that produces 'late onset' hyperammonaemia.

Authors:  H Morizono; M Tuchman; B S Rajagopal; M T McCann; C D Listrom; X Yuan; D Venugopal; G Barany; N M Allewell
Journal:  Biochem J       Date:  1997-03-01       Impact factor: 3.857

3.  Identification of Staphylococcus aureus proteins recognized by the antibody-mediated immune response to a biofilm infection.

Authors:  Rebecca A Brady; Jeff G Leid; Anne K Camper; J William Costerton; Mark E Shirtliff
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

4.  Structural similarity between ornithine and aspartate transcarbamoylases of Escherichia coli: implications for domain switching.

Authors:  L B Murata; H K Schachman
Journal:  Protein Sci       Date:  1996-04       Impact factor: 6.725

5.  Probing remote residues important for catalysis in Escherichia coli ornithine transcarbamoylase.

Authors:  Lisa Ngu; Jenifer N Winters; Kien Nguyen; Kevin E Ramos; Nicholas A DeLateur; Lee Makowski; Paul C Whitford; Mary Jo Ondrechen; Penny J Beuning
Journal:  PLoS One       Date:  2020-02-06       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.